Madison Square Garden (MSG) is currently in the process of breaking itself up again, this time into a sports team business (ex. Knicks and Rangers) and a venue/concerts business. Naturally, this has led to more people taking a look at the name and the upcoming catalyst has Barron’s thinking the company offers a lot of upside. The company’s… Read More »
From its spinoff from Biogen(BIIB) in February 2017 to the closing of its acquisition by Sanofi(SNY) in March 2018, Bioverativ’s tenure as a public company was short but profitable. From an initial price of $44.98 to the sale price of $105 in cash, Bioverativ stock, trading under the symbol BIVV, increased 133%. Not bad for 13 months. We… Read More »
Last Friday we wrote about Tronc(TRNC), the company formerly known as Tribune Publishing. Catching up on our reading, we came across a bullish piece from last week’s Barron’s on Tronc’s former parent, Tribune Media(TRCO). Despite a 30% increase in the last month, in part on speculation of a sale of the company, Barron’s continues to see significant upside… Read More »
Bioverativ(BIVV), a drug company focused on hemophilia and other blood disorders, was spun off by Biogen(BIIB) last week. Gabelli & Co initiated Bivoerativ stock as a buy with a value of $58, citing the company’s strong balance sheet(no debt, $325 million in cash), its limited exposure to Medicare, its potential to benefit from corporate tax reform, and its… Read More »
Sadly, not every announced spinoff actually ends up executed. For example, earlier this week we highlighted Fidelity National Venture’s (FNFV) postponement of its restaurant group spinoff while it exercises patience and awaits better ‘market conditions’. Another recently scrapped spinoff was Federal-Mogul Holding’s (FDML) planned separation of its Motorparts business from its Powertrain unit. The decision shouldn’t have come… Read More »
Just two days after setting the date for its Associated Capital Group(AC) spinoff, GAMCO Investors(GBL) has pushed it back eleven days in order to “to coincide with month-end.” One wonders what went on behind the scenes that caused the Board(and by Board, we mean Mario Gabelli) to reconsider so quickly. Presumably, the Board was previously aware that November… Read More »
Mario Gabelli has often made money off of spinoffs. Now he’s executing one. Gabelli, the CEO and controlling shareholder of GAMCO Investors(GBL), will be spinning off the company’s alternative investment management business and some assorted assets as Associated Capital Group. At 11:59PM on November 19, GAMCO shareholders as of November 12 will receive one Associated Capital Group Class… Read More »